Encision, Inc.
Device company "disappointed" in first-quarter results
Published in Physician Law Weekly, September 1st, 2004
For its first fiscal quarter ended June 30, 2004, Encision's revenues increased by 4% to $1,763,000 compared to $1,702,000 for last year's first fiscal quarter.
Net loss for the first fiscal quarter was $291,000, or $0.05 per share, compared to net income of $35,000, or $0.01 per share, for last year's first fiscal quarter.
Gross margin as a percentage of sales increased to 57.6% in the first quarter ended June 30, 2004 from 57.0% in the first quarter ended June 30,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2004-09-01)
More Articles from Physician Law Weekly
- Abbott Laboratories
Government decides not to intervene and force down AIDS drug price - Archemix Corp.
Biopharmaceutical company names vice president of business development - Best Practices, LLC
Drug companies approach brand security issue head on, study shows - Business Update
Altria sees $25 million gain from accounting rule - Ciphergen Biosystems Inc.
Report published on biomarkers for early diagnosis of intra-amniotic infection - CytRx Corp.
RNAi company names Benjamin S. Levin general counsel - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
